Neurocrine Biosciences shares owned by Blueshift Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Blueshift Asset Management
from 13F filings
Historical chart of Blueshift Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Blueshift Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $494k | 4.3k | 115.22 |
| 2024-03-31 | $373k | 2.7k | 137.92 |
| 2023-06-30 | $423k | 4.5k | 94.30 |
| 2022-03-31 | $249k | 2.7k | 93.82 |
| 2021-12-31 | $371k | 4.4k | 85.17 |
| 2021-03-31 | $206k | 2.1k | 97.17 |
| 2019-06-30 | $243k | 2.9k | 84.55 |
More positions owned by Blueshift Asset Management
View all positions for Blueshift Asset Management